Elsevier Inc.

SHERPA: Unknown

People

  1. Kris
    Kris
  2. Riely
    Riely
  3. Drilon
    Drilon
  4. Rudin
    Rudin
  5. Yu
    Yu
  6. Paik
    Paik
  7. Wu
    Wu
  8. Rusch
    Rusch
  9. Ladanyi
    Ladanyi
  10. Chaft
    Chaft

Groups

  1. Department of Medicine (734)
  2. Solid Tumor Oncology Division (734)
  3. Thoracic Oncology (734)
  4. GSK Faculty (182)
  5. Department of Pathology and Laboratory Medicine (138)
  6. Surgery (138)
  7. Weinberg Fellows (118)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (115)
  9. Radiation Oncology, Department of (108)
  10. Sloan Kettering Institute Postdocs (91)
Search Within
  1. "Thoracic Oncology"
Formats
  1. Meeting Abstract (488)
  2. Journal Article (215)
  3. Review (10)
  4. Conference Paper (8)
  5. Editorial (6)
  6. Correspondence (4)
  7. Research Letter (2)
  8. Book Section (1)
Groups
  1. Department of Medicine (734)
  2. Solid Tumor Oncology Division (734)
  3. Thoracic Oncology (734)
  4. GSK Faculty (182)
  5. Department of Pathology and Laboratory Medicine (138)
  6. Surgery (138)

More Groups

People
  1. Mark Kris (179)
  2. Gregory Riely (136)
  3. Alexander Drilon (118)
  4. Charles Rudin (105)
  5. Andreas Rimner (103)
  6. Jamie Chaft (102)

More People

Years
  1. 2025 (19)
  2. 2024 (58)
  3. 2023 (68)
  4. 2022 (64)
  5. 2021 (88)
  6. 2020 (28)

More Years

Publications
  1. Journal of Thoracic Oncology (513)
  2. International Journal of Radiation Oncology, Biology, Physics (89)
  3. European Journal of Cancer (42)
  4. Clinical Lung Cancer (22)
  5. Seminars in Oncology (18)
  6. Radiotherapy and Oncology (11)

More Publications

Results (734)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intracranial disease control and survival among patients with KRAS-mutant lung adenocarcinoma and brain metastases treated with stereotactic radiosurgery
    Journal Article

    Gaeta, B.; Eichholz, J. E.; Walch, H.; Ilica, A. T.; Boe, L.; Kratochvil, L.; Yu, Y.; Gomez, D. R.; Imber, B. S.; Li, B. T.; more...
    International Journal of Radiation Oncology, Biology, Physics (2025)

    Fulltext@MSK | Save
  • Tumor immunophenotypic correlates in patients aged 80 years or older with non-small cell lung cancer and outcomes to first-line pembrolizumab in PD-L1 high (≥50%) patients
    Journal Article

    Barrichello, A. P. C.; Elkrief, A.; Ricciuti, B.; Ganta, T.; Marron, T. U.; Wang, X.; Lotter, W.; Lindsay, J.; Santo, V.; Cortellini, A.; more...
    Clinical Lung Cancer (2025)

    Fulltext@MSK | Save
  • Osimertinib (osi) + datopotamab deruxtecan (Dato-DXd) in patients (pts) with EGFR-mutated (EGFRm) advanced NSCLC (aNSCLC) whose disease progressed on first-line (1L) osi: ORCHARD
    Meeting Abstract

    Le, X.; Hendriks, L.; Morabito, A.; Bonanno, L.; Okamoto, I.; Goldman, J. W.; Yu, H. A.; Brustugun, O. T.; Halvorsen, T. O.; Kim, Y. J.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Tepotinib in patients (pts) with METexon 14 (METex14) skipping non-small cell lung cancer (NSCLC) from the VISION study: ≥3-year follow-up outcomes
    Meeting Abstract

    Mazieres, J.; Veillon, R.; Cortot, A.; Ferrara, R.; Felip, E.; Garassino, M.; Le, X.; Thomas, M.; Sakai, H.; Smit, E.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Safety and clinical activity of daraxonrasib (RMC-6236) in RAS mutant non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Punekar, S. R.; Hong, D. S.; Luo, J.; Ou, S. H. I.; Johnson, M. L.; Spira, A.; Garrido-Laguna, I.; Goldman, J. W.; Herzberg, B.; Saltos, A.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Dual Targeting of RET and SRC to Treat RET-Positive Non-Small Cell Lung Cancer
    Meeting Abstract

    Son, J.; Rix, L. L. R.; Fang, B.; Welsh, E. A.; Drilon, A.; Koomen, J. M.; Cocco, E.; Rix, U.
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Chemo-immunotherapy for borderline resectable and unresectable NSCLC
    Meeting Abstract

    Cappuzzo, F.; Landi, L.; Garbo, E.; Cooper, A.; Wang, X.; Mayoral, M.; Ginsberg, M. S.; Sholl, L.; Nishino, M.; Bott, M.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Phase I study of patritumab deruxtecan (HER3-DXd) in patients (pts) with advanced KRAS G12C non-small cell lung cancer (NSCLC): Study U102 cohort 5
    Meeting Abstract

    Paz-Ares, L.; Steuer, C.; Ruiter, G.; Nishio, M.; Murakami, H.; Kim, D. W.; Felip, E.; Baik, C. S.; Lin, C. C.; Massarelli, E.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • A randomized phase III study of ivonescimab versus pembrolizumab as first-line treatment of metastatic non-small cell lung cancer as first-line treatment of metastatic non-small cell lung cancer with high tumor PD-L1 expression: HARMONi-7
    Meeting Abstract

    Passaro, A.; Girard, N.; Rodriguez Abreu, D.; Gumus, M.; Wu, Y. L.; Syrigos, K.; Ramlau, R.; Santos, E.; Berz, D.; Gandhi, C.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • TROPION-Lung15: A phase III study of datopotamab deruxtecan (Dato-DXd) ± osimertinib vs platinum doublet chemotherapy in patients with EGFR-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) and disease progression on prior osimertinib
    Meeting Abstract

    Nadal, E.; Cheema, P. K.; Wu, Y. L.; Ahn, M. J.; Tanizaki, J.; Gharagoozloo, S.; Nizialek, E.; Shi, X.; van der Gronde, T.; Yu, H. A.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save